HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beverly H Koller Selected Research

Schizophrenia (Dementia Praecox)

1/2016Reversal of social deficits by subchronic oxytocin in two autism mouse models.
3/2012Effects of the selective kainate receptor antagonist ACET on altered sensorimotor gating in a genetic model of reduced NMDA receptor function.
1/2012Preweaning sensorimotor deficits and adolescent hypersociability in Grin1 knockdown mice.
1/2010Increased sensitivity to kainic acid in a genetic model of reduced NMDA receptor function.
4/2009Neural activation deficits in a mouse genetic model of NMDA receptor hypofunction in tests of social aggression and swim stress.
11/2006Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction.
5/2006Amphetamine-induced disruption of prepulse inhibition in mice with reduced NMDA receptor function.
1/2006Effects of haloperidol, clozapine, and quetiapine on sensorimotor gating in a genetic model of reduced NMDA receptor function.
12/2004Amphetamine-induced Fos is reduced in limbic cortical regions but not in the caudate or accumbens in a genetic model of NMDA receptor hypofunction.
8/2004Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Beverly H Koller Research Topics

Disease

14Inflammation (Inflammations)
05/2024 - 07/2003
10Schizophrenia (Dementia Praecox)
01/2016 - 08/2004
7Asthma (Bronchial Asthma)
01/2023 - 04/2003
5Infections
05/2024 - 10/2013
5Hypertension (High Blood Pressure)
10/2022 - 09/2005
4Sepsis (Septicemia)
11/2017 - 08/2005
3Pneumonia (Pneumonitis)
11/2021 - 03/2007
3Anaphylaxis (Anaphylactic Shock)
05/2010 - 01/2007
2Insulin Resistance
12/2023 - 11/2017
2Eosinophilia
11/2021 - 03/2012
2Respiratory Hypersensitivity
11/2021 - 03/2012
2Gram-Negative Bacterial Infections
11/2020 - 05/2019
2Shock
11/2017 - 01/2013
2Hypersensitivity (Allergy)
04/2012 - 05/2010
2Lung Diseases (Lung Disease)
01/2012 - 08/2006
2Fibrosis (Cirrhosis)
08/2006 - 09/2005
2Neoplasms (Cancer)
06/2006 - 12/2005
1Animal Disease Models
05/2024
1Type 2 Diabetes Mellitus (MODY)
12/2023
1Prostatic Neoplasms (Prostate Cancer)
01/2021
1Peritonitis
12/2019
1Autoimmune Diseases (Autoimmune Disease)
01/2018
1Blister (Bulla)
01/2018
1Bullous Pemphigoid (Pemphigoid)
01/2018
1Hypoglycemia (Reactive Hypoglycemia)
11/2017
1Arthritis (Polyarthritis)
12/2016
1Osteoporosis
12/2016
1Autistic Disorder (Autism)
01/2016
1Toxoplasmosis
02/2014
1Bites and Stings (Sting)
10/2013
1Cardiovascular Diseases (Cardiovascular Disease)
01/2013
1Vascular Remodeling
01/2013
1Sudden Death
01/2013
1Acute Lung Injury
08/2012
1Anthrax
08/2012
1Contact Dermatitis (Eczema, Contact)
08/2012

Drug/Important Bio-Agent (IBA)

9N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2016 - 08/2004
7ProstaglandinsIBA
10/2022 - 07/2004
6InflammasomesIBA
05/2024 - 08/2012
5CytokinesIBA
05/2024 - 03/2007
5Proteins (Proteins, Gene)FDA Link
01/2018 - 11/2006
5Thromboxane Receptors (Thromboxane Receptor)IBA
01/2013 - 12/2003
4Angiotensin IIIBA
10/2022 - 02/2010
4Immunoglobulin E (IgE)IBA
11/2021 - 01/2007
4Prostaglandins EIBA
01/2019 - 04/2003
4Dinoprostone (PGE2)FDA Link
01/2014 - 07/2004
4N-Methylaspartate (NMDA)IBA
01/2012 - 01/2006
3Anti-Bacterial Agents (Antibiotics)IBA
11/2020 - 05/2019
3Colistin (Coly-Mycin)FDA Link
11/2020 - 05/2019
3ThromboxanesIBA
01/2013 - 02/2010
2SodiumIBA
05/2024 - 10/2022
2Blood Glucose (Blood Sugar)IBA
12/2023 - 11/2017
2Insulin (Novolin)FDA Link
12/2023 - 11/2017
2Interleukin-13IBA
01/2023 - 11/2021
2Interleukin-4 (Interleukin 4)IBA
01/2023 - 11/2021
2Protein Isoforms (Isoforms)IBA
01/2019 - 06/2007
2LipopolysaccharidesIBA
11/2017 - 08/2005
2NucleotidesIBA
02/2014 - 10/2010
2Leucine (L-Leucine)FDA Link
02/2014 - 10/2010
2Kainic Acid Receptors (Kainate Receptor)IBA
03/2012 - 01/2010
2Epoprostenol (Prostacyclin)FDA LinkGeneric
08/2006 - 09/2005
2Amphetamine (Amfetamine)FDA LinkGeneric
05/2006 - 12/2004
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
07/2004 - 12/2003
1InterleukinsIBA
05/2024
1Glucose (Dextrose)FDA LinkGeneric
12/2023
1ArsenicIBA
12/2023
1Antihypertensive Agents (Antihypertensives)IBA
10/2022
1OxysterolsIBA
11/2021
1Conjugate VaccinesIBA
11/2021
1OzoneIBA
11/2021
1Small Interfering RNA (siRNA)IBA
11/2021
1Air Pollutants (Pollutants, Air)IBA
11/2021
1Monoclonal AntibodiesIBA
11/2021
1AntibodiesIBA
11/2021
1Azacitidine (5 Azacytidine)FDA Link
01/2021
1Epidermal Growth Factor (EGF)IBA
01/2021
1MethyltransferasesIBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1Uridine Diphosphate (UDP)IBA
01/2021
1Antimicrobial PeptidesIBA
11/2020
1Phosphotransferases (Kinase)IBA
11/2020
1Polymyxins (Polymyxin)IBA
05/2019
1AutoantibodiesIBA
01/2018
1IgE Receptors (Fc epsilon RI)IBA
01/2018
1Hypoglycemic Agents (Hypoglycemics)IBA
11/2017
1Indicators and Reagents (Reagents)IBA
12/2016
1EndotoxinsIBA
12/2016
1Oxytocin (Pitocin)FDA LinkGeneric
01/2016
1Interleukin-18 (Interleukin 18)IBA
02/2014
1Caspase 1 (ICE Protease)IBA
02/2014
1Prostaglandin E Receptors (Prostaglandin E Receptor)IBA
01/2014
1Carrier Proteins (Binding Protein)IBA
10/2013
1Interferon Type IIBA
10/2013
1Pathogen-Associated Molecular Pattern MoleculesIBA
10/2013
115-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidIBA
01/2013
1Thromboxane A2 (A2, Thromboxane)IBA
01/2013
1AntigensIBA
08/2012
1HaptensIBA
08/2012
1LipidsIBA
04/2012

Therapy/Procedure

3Therapeutics
05/2024 - 07/2004